Nathanial Marchetti, DO, Assistant Professor of Medicine, Section of Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses a clinical study involving early goal directed therapy in the treatment of sepsis.

References and Resources
Rivers E, Nguyen B, Havstad Suzanne, Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock. Nov 2001;Volume 345:1368-1377.
Click Here to read the study Dr. Marchetti discusses.

Neurath M, New therapies for sepsis: focus on the interleukin (IL)12 family member IL27. Annals of the Rheumatic Diseases, 2007;66.
Click Here to read abstract.

ESMON C, Is APC activation of endothelial cell PAR1 important in severe sepsis?: No. Journal of Thrombosis and Hemostasis, 2005; 3(9):1910–1911.
Click Here to read abstract.

Al-Abed Y, Dabideen D, Aljabari B, et al., SO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis. J. Biol. Chem., 2005; Vol. 280:44, 36541-36544.
Click Here to read article.